Our latest white paper explores the rigorous clinical validation behind Biobeat’s FDA-cleared, medical-grade, cuffless PPG-based chest patch. The paper highlights a pivotal Mayo Clinic study demonstrating strong correlation and minimal bias when compared with invasive arterial blood pressure monitoring, reinforcing the technology’s accuracy and reliability.
Why It Matters
Effective hypertension management requires more than medication adjustments or occasional clinic-based measurements. It demands access to 24-hour, medical-grade blood pressure data that can reveal critical patterns and support more accurate diagnosis, treatment decisions, and improved patient outcomes.
Click here to read our latest white paper and discover how clinically validated, 24-hour blood pressure monitoring can support better hypertension management.
To schedule a demo of how Biobeat works or to learn more about how Biobeat’s cuffless Blood Pressure monitors can help improve HTN diagnostics and treatment, contact: info@bio-beat.com.